Status:

COMPLETED

Assessment of the Prognostic Value of the Thickness of the Quadriceps and Abdominal Muscles Measured by Ultrasound for 28-day Mortality in Postoperative ICU Patients

Lead Sponsor:

Centre Hospitalier Universitaire Dijon

Conditions:

Sarcopenia ICU Ultrasound

Eligibility:

All Genders

18+ years

Brief Summary

Ultrasound measurement of muscle thickness, particularly of the quadriceps, can be used to highlight a reduction in lean mass. Sarcopenia is annvoluntary loss of lean mass, and it is a frequent and ma...

Eligibility Criteria

Inclusion

  • Person who has not opposed (or non-opposition of health care proxy for patients who are comatose or under the influence of sedative drugs) after receiving information about the study
  • All adult patients admitted to the postoperative intensive care unit.

Exclusion

  • Protected adult or minor
  • Pregnant or breastfeeding woman
  • Lower limb amputation
  • Refusal to participate of the patient or health care proxy
  • Patient with pre-existing neuromuscular condition, tetra or paraplegia
  • Morbid obesity as defined by BMI ≥ 40
  • BPCO stage ≥ 3; heart failure with LVEF \< 50%; patients with symptomatic valvulopathy

Key Trial Info

Start Date :

December 20 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 26 2020

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT05276921

Start Date

December 20 2019

End Date

June 26 2020

Last Update

March 14 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Chu Dijon Bourgogne

Dijon, France

Assessment of the Prognostic Value of the Thickness of the Quadriceps and Abdominal Muscles Measured by Ultrasound for 28-day Mortality in Postoperative ICU Patients | DecenTrialz